Quantcast

Latest Regenerative medicine Stories

2014-05-12 08:33:28

ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2014 and provided a business and clinical update. "During the first quarter of 2014, we continued to advance the NSI-566 cell therapy platform through human clinical trials. We have completed treatment of the fourth cohort in our ALS Phase II escalating dose trials, in collaboration with our sites at University of Michigan, Emory and...

2014-05-12 08:33:04

SAN DIEGO, May 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced that the Company's Excellagen(®) flowable dermal matrix in combination with Orbsen Therapeutics' mesenchymal stromal stem cell therapy Cyndacel-M(TM) has been selected for clinical evaluation in a Phase 1b safety study for the potential treatment of chronic diabetic wounds to be funded by the European Union under EU Framework 7 (FP7). The project, known by the...

2014-05-08 12:30:08

Two new gifts will benefit faculty in stem cell science and digestive diseases LOS ANGELES, May 8, 2014 /PRNewswire-USNewswire/ -- Two new gifts from The Eli and Edythe Broad Foundation to UCLA totaling $4 million will fund research in stem cell science and digestive diseases and support the recruitment of key faculty at two renowned research centers. The gifts bring to $30 million The Broad Foundation's total support of faculty recruitment and basic and translational research at...

2014-05-07 12:29:37

NEW YORK, May 7, 2014 /PRNewswire/ -- IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has received a final positive ruling in its case against Ironridge Global IV, LTD. ("Ironridge"), and TCA Global Credit Master Fund, LP ("TCA"). On May 5, 2014 Judge Jeffrey K. Oing "ORDERED that the motion by...

2014-05-06 08:36:03

CLEVELAND, May 6, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics today announced that top-line interim data from its ongoing Phase II STOP-HF study will be presented in a late-breaking oral presentation at the European Society of Cardiology Heart Failure Congress (ESC-HF) taking place May 17 - 20, 2014 in Athens, Greece. The STOP-HF trial is a randomized, placebo-controlled, double-blinded study conducted at 15 centers in the United States to evaluate safety and efficacy of...

2014-05-05 23:06:09

A new study released today in STEM CELLS Translational Medicine demonstrates the regenerative effects of mesenchymal stem cells (MSC) on the anal sphincter. The work could have implications for the 11 percent of the population suffering fecal incontinence due to an injury or disease. Durham, NC (PRWEB) May 05, 2014 A new study released today in STEM CELLS Translational Medicine demonstrates the regenerative effects of mesenchymal stem cells (MSC) on the anal sphincter. The work could have...

2014-05-05 23:00:23

Tennis elbow is a common condition affecting 40-60 years aged adults. Though it is not a critical condition, it is potentially disabling in the sense that it restricts the certain activities of tennis players. Los Angeles, CA (PRWEB) May 05, 2014 Tennis elbow is a common condition affecting 40-60 years aged adults. Though it is not a critical condition, it is potentially disabling in the sense that it restricts the certain activities of tennis players. MetroMD Institute of Regenerative...

Stem Cell Therapy Regenerates Heart Muscle After Heart Attacks: Animal Trials
2014-05-01 07:02:06

April Flowers for redOrbit.com - Your Universe Online When a heart attack occurs, the oxygen-rich blood that normally flows through is interrupted by the blockage in an artery. The longer that blood flow is restricted or cut off, the more tissue and muscle in the area dies or is scarred. The eventual result can be heart failure, especially if one heart attack is followed by another. In 2013, Harvard Health Publications released a report taking a look at the state of stem cell research...

2014-04-30 23:25:59

The Global Stem Cells Foundation in Buenos Aires, Argentina will host its first International Symposium on Stem Cell Research at the Sheraton Buenos Aires Hotel and Resort October. Miami (PRWEB) April 29, 2014 Global Stem Cells, Inc. and Global Stem Cell Foundation have announced plans to host the First International Symposium on Stem Cell Research in Buenos Aires, Argentina Oct. 2-4 2014. Some of the world’s leading stem cell researchers, treatment practitioners and investors, all...

2014-04-30 23:03:07

Further study this April from an initial study published on January 14, 2014 at MetroMD Institute of Regenerative Medicine regarding Human Growth Hormone Therapy, alternatively known as HGH Therapy, shows how it improves short stature in children, http://metromd.net/sermorelin-hgh-the-newest-measure-for-treating-children-of-short-stature/. In 2003, growth hormone therapy was approved in United States for children with idiopathic short stature with a height at or higher than 2.25 standard...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related